Detalhe da pesquisa
1.
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.
Br J Cancer
; 123(10): 1481-1489, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839491
2.
Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain.
J Virol
; 82(17): 8373-82, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18596106
3.
AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes.
J Biol Chem
; 280(20): 19656-64, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15749704